Bioprocessing Poster

Optimizing Viral Vector Production and Efficiency While Saving Potential Costs with Osmolality

Here, brand new data from a study by the Cell and Gene Therapy Catapult, completed in June 2021 is presented. It shows that a significant increase in yield and quality of an AAV was realized from a timed osmolality shift. Additionally, this data will show how the shift had a profound effect on the relative extracellular vs intracellular vector yield, with the potential to significantly reduce time and costs within viral vector manufacturing.

Download Poster

Please fill out this brief form to download this content.

One moment while the form loads...

Please note, browsing in private or incognito may not be supported and may not allow forms and other elements to load correctly.